Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hyperthermia
Comorbidity C0242379|lung cancer
Sentences 10
PubMedID- 24679653 We assessed the efficacy and safety of cefepime monotherapy (1 g intravenously every 8 h) for febrile neutropenia in patients with lung cancer in a multi-institutional phase ii study.
PubMedID- 21773751 Identifying risk factors for refractory febrile neutropenia in patients with lung cancer.
PubMedID- 23053498 Elevation of serum c-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer.
PubMedID- 21707992 Bacterial infection profiles in lung cancer patients with febrile neutropenia.
PubMedID- 26024659 Psychogenic fever in a patient with small cell lung cancer: a case report.
PubMedID- 19699672 In this report, we describe an unusual case of non-metastatic non-small cell lung cancer (nsclc) presenting with neoplastic fever at both diagnosis and relapse, responding on each occasion to disease-specific treatment, and provide a review of the management of neoplastic fever.
PubMedID- 26082648 A 30-year-old female patient previously treated with crizotinib harboring alk rearranged non-small cell lung cancer complained of visual disturbance, fever, and bone pains undergoing anti-pd-1 antibody treatment.
PubMedID- 26434104 Pentraxin-3 as a biomarker for febrile neutropenia in patients with lung cancer.
PubMedID- 20130951 Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer.
PubMedID- 22085873 Discussion and conclusions: though rare, aosd-like pns can be one of the potential diagnoses in lung cancer patients with fever of undetermined origin, especially those having no response to antibiotic treatment.

Page: 1